Established in New Delhi, India in 2020, ImpoMed Healthcare has grown over the years from a new start-up to one of the Most Preferred Companies to Facilitate the SOURCING Process of Imported Drugs (only USFDA/European FDA Approved), which are currently not approved by the Drug Controller General of India (DCGI) for importing, marketing and selling but are required by the Indian Patients for their treatments of diseases like Cancer, Multiple Sclerosis, Chronic Migraine, Headache, Diabetes, Infections, HIV etc.
To be the Numero Uno Company in India, in the Space of Facilitation of SOURCING of Imported Medicines by the end of 2024.
To foster a work culture that respects patients’ Needs with Empathy and Govt of India’s Approved Processes while facilitating the SOURCING of Imported Medicines on Name Patient Basis, in India.
In today’s scenario, there are many medicines that are currently being used worldwide for the treatment of various diseases in the fields of Oncology, Neurology, Endocrinology, Urology, etc. All such medicines have been approved by the USFDA/European FDA for human use but still they are not approved by DCGI, New Delhi, for sales and marketing hence patients cannot get these medicines easily.
Since its operations in 2020, ImpoMed Healthcare has pioneered in Facilitation of Sourcing of such must-to-get medicines by the patients.
Although such USFDA/European FDA-Approved medicines are not approved in India with prior Approvals, Licenses, and Certificates issued by the Govt. of India, the patients can source such Imported Medicines in Small quantities for personal use.
We, at ImpoMed Healthcare, DO NOT SELL IMPORTED MEDICINES, WE FACILITATE THE SOURCING PROCESS of Imported Medicines.
In India, ImpoMed Healthcare charges patients neither Online/Offline nor in CASH for the Facilitation of SOURCING of Imported Medicines. We, FACILITATE the Patients for:
Form-12B issued by the Govt. of India.
To get the Pro-forma Invoice in the Patient's name from an Intern. Company.
To remit funds to the International Company’s Bank Account directly.
Follow up on the Shipment, right from the office of the Intern. Company.
Issue of Custom Duty Exemption Certificate (CDEC) issued by the Govt. of India to waive off import duty of 18%-28%.
Assistance in the Customs Clearance of the Shipment.
Make the Shipment reach the patient's place in India, well on time.
Doctors divide cancer into two main types: Solid Tumor Cancers and Cancers in the Blood. Cancers in the blood are also called hematological cancers. Cancers in the blood don't form Tumors. In hospitals, doctors who treat solid Tumors are often in a different department than those who treat blood cancers.
Multiple sclerosis (MS) is an autoimmune disease. With these conditions, your immune system mistakenly attacks healthy cells. In people with MS, the immune system attacks cells in the myelin, the protective sheath that surrounds nerves in the brain and spinal cord.
Endocrinology (from endocrine + -ology) is a branch of biology
and
medicine dealing with the endocrine system, its diseases, and
its
specific secretions known as hormones.
Hormones are essential for our every-day survival. They control
our
temperature, sleep, mood, stress, growth and more.
Viruses are tiny (microscopic) infectious agents that grow and multiply only inside living cells of an organism.
Antivirals are medications that help your body fight off certain viruses that can cause disease.
Injection
Crovalimab-akkz, a complement C5 inhibitor, is a humanized monoclonal antibody based on a human IgG1 framework. The recombinant antibody is produced in Chinese hamster ovary CHO cells and consists of...
Crovalimab-akkz, a complement C5 inhibitor, is a humanized monoclonal antibody based on a human IgG1 framework. The recombinant antibody is produced in Chinese hamster ovary CHO cells and consists of...
View ProductInjection
Tarlatamab-dlle is a bispecific DLL3-directed CD3 T-cell engager that binds to DLL3 expressed on the surface of cells, including tumor cells, and CD3 expressed on the surface of T cells. Tarlatamab-dl...
Tarlatamab-dlle is a bispecific DLL3-directed CD3 T-cell engager that binds to DLL3 expressed on the surface of cells, including tumor cells, and CD3 expressed on the surface of T cells. Tarlatamab-dl...
View ProductInjection
OJEMDA contains tovorafenib, a kinase inhibitor. Tovorafenib has the molecular formula C17H12Cl2F3N7O2S and a molecular weight of 506.29. The chemical name for tovorafenib is 6-amino-5-chloro-N-[(1R)-...
OJEMDA contains tovorafenib, a kinase inhibitor. Tovorafenib has the molecular formula C17H12Cl2F3N7O2S and a molecular weight of 506.29. The chemical name for tovorafenib is 6-amino-5-chloro-N-[(1R)-...
View ProductInjection
Tisotumab vedotin-tftv is a Tissue Factor (TF) directed antibody drug conjugate (ADC) comprised of a human anti-TF IgG1-kappa antibody conjugated to the microtubule-disrupting agent monomethyl aurista...
Tisotumab vedotin-tftv is a Tissue Factor (TF) directed antibody drug conjugate (ADC) comprised of a human anti-TF IgG1-kappa antibody conjugated to the microtubule-disrupting agent monomethyl aurista...
View ProductInjection
Breyanzi (lisocabtagene maraleucel) is a CD19-directed genetically modified autologous cell-based product consisting of purified CD8+ and CD4+ T cells, in a defined composition, that have been separat...
Breyanzi (lisocabtagene maraleucel) is a CD19-directed genetically modified autologous cell-based product consisting of purified CD8+ and CD4+ T cells, in a defined composition, that have been separat...
View ProductCapsule
Repotrectinib is a kinase inhibitor. The molecular formula for repotrectinib is C18H18FN5O2 and the molecular weight is 355.37 Daltons. The chemical name is (3R,11S)-6-Fluoro-3,11-dimethyl10-oxa-2,13...
Repotrectinib is a kinase inhibitor. The molecular formula for repotrectinib is C18H18FN5O2 and the molecular weight is 355.37 Daltons. The chemical name is (3R,11S)-6-Fluoro-3,11-dimethyl10-oxa-2,13...
View ProductInjection
Epcoritamab-bysp is a bispecific CD20-directed CD3 T-cell engager; it is a humanized bispecific IgG1 antibody. Epcoritamab-bysp is manufactured in Chinese hamster ovary (CHO) cells using recombinant D...
Epcoritamab-bysp is a bispecific CD20-directed CD3 T-cell engager; it is a humanized bispecific IgG1 antibody. Epcoritamab-bysp is manufactured in Chinese hamster ovary (CHO) cells using recombinant D...
View ProductTablet
Pirtobrutinib is a kinase inhibitor. It is an orally available, small molecule ATP-competitive inhibitor of BTK. The active pharmaceutical ingredient is pirtobrutinib with the molecular formula C22H21...
Pirtobrutinib is a kinase inhibitor. It is an orally available, small molecule ATP-competitive inhibitor of BTK. The active pharmaceutical ingredient is pirtobrutinib with the molecular formula C22H21...
View ProductTablet
Belzutifan is an inhibitor of hypoxia-inducible factor-2α (HIF-2α). The chemical name of belzutifan is 3 [[(1S,2S,3R)-2,3-Difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5 fluor...
Belzutifan is an inhibitor of hypoxia-inducible factor-2α (HIF-2α). The chemical name of belzutifan is 3 [[(1S,2S,3R)-2,3-Difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5 fluor...
View ProductTablet
Tepotinib is a kinase inhibitor. TEPMETKO (tepotinib) tablets for oral use are formulated with tepotinib hydrochloride hydrate. The chemical name for tepotinib hydrochloride hydrate is 3-{1-[(3-{5-[(1...
Tepotinib is a kinase inhibitor. TEPMETKO (tepotinib) tablets for oral use are formulated with tepotinib hydrochloride hydrate. The chemical name for tepotinib hydrochloride hydrate is 3-{1-[(3-{5-[(1...
View ProductInjection
Amivantamab-vmjw is a low-fucose human immunoglobulin G1-based bispecific antibody directed against the EGF and MET receptors, produced by mammalian cell line (Chinese Hamster Ovary [CHO]) using recom...
Amivantamab-vmjw is a low-fucose human immunoglobulin G1-based bispecific antibody directed against the EGF and MET receptors, produced by mammalian cell line (Chinese Hamster Ovary [CHO]) using recom...
View ProductTablet
TRUQAP (capivasertib) is a kinase inhibitor. The molecular formula for capivasertib is C21H25ClN6O2 and the molecular weight is 428.92 g/mol. The chemical name of capivasertib is 4-amino-N-[(1S)-1-(4-...
TRUQAP (capivasertib) is a kinase inhibitor. The molecular formula for capivasertib is C21H25ClN6O2 and the molecular weight is 428.92 g/mol. The chemical name of capivasertib is 4-amino-N-[(1S)-1-(4-...
View ProductInjection
Epcoritamab-bysp is a bispecific CD20-directed CD3 T-cell engager; it is a humanized bispecific IgG1 antibody. Epcoritamab-bysp is manufactured in Chinese hamster ovary (CHO) cells using recombinant D...
Epcoritamab-bysp is a bispecific CD20-directed CD3 T-cell engager; it is a humanized bispecific IgG1 antibody. Epcoritamab-bysp is manufactured in Chinese hamster ovary (CHO) cells using recombinant D...
View ProductInjection
Mirvetuximab soravtansine-gynx is a folate receptor alpha (FRα)-directed antibody-drug conjugate (ADC) consisting of three components: 1) an anti-FRα monoclonal antibody of IgG1 subtype 2) the small m...
Mirvetuximab soravtansine-gynx is a folate receptor alpha (FRα)-directed antibody-drug conjugate (ADC) consisting of three components: 1) an anti-FRα monoclonal antibody of IgG1 subtype 2) the small m...
View ProductCapsule
Fruquintinib is a kinase inhibitor with the chemical name 6-[(6,7-dimethoxyquinazolin-4-yl)oxy]-N,2- dimethyl-1-benzofuran-3-carboxamide. Its molecular formula is C21H19N3O5, which corresponds to a mo...
Fruquintinib is a kinase inhibitor with the chemical name 6-[(6,7-dimethoxyquinazolin-4-yl)oxy]-N,2- dimethyl-1-benzofuran-3-carboxamide. Its molecular formula is C21H19N3O5, which corresponds to a mo...
View ProductInjection
Toripalimab-tpzi is a programmed death receptor-1 (PD-1) blocking antibody. Toripalimab-tpzi is a humanized immunoglobulin G4 (IgG4) kappa immunoglobulin that has a predicted molecular weight of a...
Toripalimab-tpzi is a programmed death receptor-1 (PD-1) blocking antibody. Toripalimab-tpzi is a humanized immunoglobulin G4 (IgG4) kappa immunoglobulin that has a predicted molecular weight of a...
View ProductCapsule
Pralsetinib is an oral receptor tyrosine kinase inhibitor. The chemical name for pralsetinib is (cis)-N-((S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-(5 methyl-1H-py...
Pralsetinib is an oral receptor tyrosine kinase inhibitor. The chemical name for pralsetinib is (cis)-N-((S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-(5 methyl-1H-py...
View ProductTablets
VANFLYTA (quizartinib) is a kinase inhibitor for oral use. The chemical name of quizartinib dihydrochloride is 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-(4-{7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1- b][1,3]be...
VANFLYTA (quizartinib) is a kinase inhibitor for oral use. The chemical name of quizartinib dihydrochloride is 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-(4-{7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1- b][1,3]be...
View ProductInjection
Tremelimumab-actl, a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking human IgG2 monoclonal antibody, is produced by recombinant DNA technology in NS0 cell suspension culture and has a...
Tremelimumab-actl, a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking human IgG2 monoclonal antibody, is produced by recombinant DNA technology in NS0 cell suspension culture and has a...
View ProductInjection
SILTUXIMAB 100 / 400 MG INJECTION<br> SYLVANT (siltuximab) is a human-mouse chimeric monoclonal antibody that binds human interleukin-6 (IL-6). SYLVANT is produced by Chinese hamster ovary cells. SYL...
SILTUXIMAB 100 / 400 MG INJECTION<br> SYLVANT (siltuximab) is a human-mouse chimeric monoclonal antibody that binds human interleukin-6 (IL-6). SYLVANT is produced by Chinese hamster ovary cells. SYL...
View ProductInjection
DEFIBROTIDE 200 MG INJECTION <br> Defibrotide sodium is an oligonucleotide mixture with profibrinolytic properties. The chemical name of defibrotide sodium is polydeoxyribonucleotide, sodium salt. De...
DEFIBROTIDE 200 MG INJECTION <br> Defibrotide sodium is an oligonucleotide mixture with profibrinolytic properties. The chemical name of defibrotide sodium is polydeoxyribonucleotide, sodium salt. De...
View ProductInjection
TAFACITAMAB 200 MG INJECTION<br> Tafasitamab-cxix is a humanized CD19-directed cytolytic monoclonal antibody that contains an IgG1/2 hybrid Fc-domain with 2 amino acid substitutions to modify the Fc-...
TAFACITAMAB 200 MG INJECTION<br> Tafasitamab-cxix is a humanized CD19-directed cytolytic monoclonal antibody that contains an IgG1/2 hybrid Fc-domain with 2 amino acid substitutions to modify the Fc-...
View ProductCapsule
TIVOZANIB 890 / 1340 MCG CAPSULE<br> Tivozanib is a kinase inhibitor.FOTIVDA 1.34 mg capsule contains 1.5 mg of tivozanib hydrochloride (equivalent to 1.34 mg tivozanib) with inactive ingredients: m...
TIVOZANIB 890 / 1340 MCG CAPSULE<br> Tivozanib is a kinase inhibitor.FOTIVDA 1.34 mg capsule contains 1.5 mg of tivozanib hydrochloride (equivalent to 1.34 mg tivozanib) with inactive ingredients: m...
View ProductTABLET
SOTORASIB 120 MG TABLET<br> Sotorasib is an inhibitor of the RAS GTPase family. LUMAKRAS is supplied as film-coated tablets for oral use containing 120 mg of sotorasib. Inactive ingredients in the ta...
SOTORASIB 120 MG TABLET<br> Sotorasib is an inhibitor of the RAS GTPase family. LUMAKRAS is supplied as film-coated tablets for oral use containing 120 mg of sotorasib. Inactive ingredients in the ta...
View ProductCapsule
COBIMETINIB 20 MG CAPSULE<br> Cobimetinib is a fumarate salt appearing as white to off-white solid and exhibits a pH dependent solubility. 297 COTELLIC (cobimetinib) tablets are supplied as white, ro...
COBIMETINIB 20 MG CAPSULE<br> Cobimetinib is a fumarate salt appearing as white to off-white solid and exhibits a pH dependent solubility. 297 COTELLIC (cobimetinib) tablets are supplied as white, ro...
View ProductTablets
"Erdafitinib, the active ingredient in BALVERSA, is a kinase inhibitor. BALVERSA (erdafitinib) is supplied as 3 mg, 4 mg or 5 mg film-coated tablets for oral administration and contains the following...
"Erdafitinib, the active ingredient in BALVERSA, is a kinase inhibitor. BALVERSA (erdafitinib) is supplied as 3 mg, 4 mg or 5 mg film-coated tablets for oral administration and contains the following...
View ProductInjection
"Romidepsin, a histone deacetylase (HDAC) inhibitor, is a bicyclic depsipeptide. ISTODAX (romidepsin) for injection is intended for intravenous infusion only after reconstitution with the supplied Dil...
"Romidepsin, a histone deacetylase (HDAC) inhibitor, is a bicyclic depsipeptide. ISTODAX (romidepsin) for injection is intended for intravenous infusion only after reconstitution with the supplied Dil...
View ProductInjection
Isatuximab-irfc, a CD38-directed cytolytic antibody, is a chimeric immunoglobulin G1 (IgG1) monoclonal antibody (mAb). SARCLISA (isatuximab-irfc) injection is a sterile, preservative-free, clear to sl...
Isatuximab-irfc, a CD38-directed cytolytic antibody, is a chimeric immunoglobulin G1 (IgG1) monoclonal antibody (mAb). SARCLISA (isatuximab-irfc) injection is a sterile, preservative-free, clear to sl...
View ProductInjection
GEMTUZUMAB 4.5 MG INJECTION <br> Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) composed of the CD33-directed monoclonal antibody. MYLOTARG (gemtuzumab ozogamicin) for Injection is supplie...
GEMTUZUMAB 4.5 MG INJECTION <br> Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) composed of the CD33-directed monoclonal antibody. MYLOTARG (gemtuzumab ozogamicin) for Injection is supplie...
View ProductInjection
*Nivolumab and relatlimab-rmbw is a fixed-dose combination of two IgG4 kappa monoclonal antibodies (mAbs). Nivolumab is a programmed death receptor-1 (PD-1) blocking antibody that has a calculated mol...
*Nivolumab and relatlimab-rmbw is a fixed-dose combination of two IgG4 kappa monoclonal antibodies (mAbs). Nivolumab is a programmed death receptor-1 (PD-1) blocking antibody that has a calculated mol...
View ProductCapsules
"Mobocertinib is a kinase inhibitor. EXKIVITY capsule for oral administration contains 40 mg mobocertinib equivalent to 48.06 mg mobocertinib succinate, with no inactive ingredients. The capsule shell...
"Mobocertinib is a kinase inhibitor. EXKIVITY capsule for oral administration contains 40 mg mobocertinib equivalent to 48.06 mg mobocertinib succinate, with no inactive ingredients. The capsule shell...
View ProductTablets
CAPRELSA (Vandetanib) tablets for daily oral administration are available in two dosage strengths containing either 100 mg or 300 mg of vandetanib. The tablet cores contain the following inactive ingr...
CAPRELSA (Vandetanib) tablets for daily oral administration are available in two dosage strengths containing either 100 mg or 300 mg of vandetanib. The tablet cores contain the following inactive ingr...
View ProductInjection
Palivizumab is a humanized monoclonal antibody (IgG1к) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of RSV. Palivizumab is a composite of hum...
Palivizumab is a humanized monoclonal antibody (IgG1к) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of RSV. Palivizumab is a composite of hum...
View ProductCapsules
ANAGRELIDE 0.5 MG CAPSULES <br> The mechanism by which anagrelide reduces blood platelet count is still under investigation. Studies in patients support a hypothesis of dose-related reduction in plat...
ANAGRELIDE 0.5 MG CAPSULES <br> The mechanism by which anagrelide reduces blood platelet count is still under investigation. Studies in patients support a hypothesis of dose-related reduction in plat...
View ProductInjection
ALKERAN (melphalan), also known as L-phenylalanine mustard, phenylalanine mustard, L-PAM, or L-sarcolysin, is a phenylalanine derivative of nitrogen mustard. Melphalan is a bifunctional alkylating age...
ALKERAN (melphalan), also known as L-phenylalanine mustard, phenylalanine mustard, L-PAM, or L-sarcolysin, is a phenylalanine derivative of nitrogen mustard. Melphalan is a bifunctional alkylating age...
View ProductTablets
SEMAGLUTIDE 3 MG, 7 MG AND 14 MG TABLETS<br> RYBELSUS (semaglutide) tablets, for oral use.
SEMAGLUTIDE 3 MG, 7 MG AND 14 MG TABLETS<br> RYBELSUS (semaglutide) tablets, for oral use.
View ProductInjection
SEMAGLUTIDE 2 MG/3 ML INJECTION <br> OZEMPIC® is a glucagon-like peptide 1 (GLP-1) receptor agonist injection for subcutaneous use.
SEMAGLUTIDE 2 MG/3 ML INJECTION <br> OZEMPIC® is a glucagon-like peptide 1 (GLP-1) receptor agonist injection for subcutaneous use.
View ProductInjection
FOSCAVIR is the brand name for foscarnet sodium. The chemical name of foscarnet sodium isphosphonoformic acid, trisodium salt. Foscarnet sodium is a white, crystalline powder containing 6 equivalents...
FOSCAVIR is the brand name for foscarnet sodium. The chemical name of foscarnet sodium isphosphonoformic acid, trisodium salt. Foscarnet sodium is a white, crystalline powder containing 6 equivalents...
View ProductInjection
ABATACEPT 250 MG INJECTION<br> ORENCIA (abatacept) is a soluble fusion protein that consists of the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) linked to the m...
ABATACEPT 250 MG INJECTION<br> ORENCIA (abatacept) is a soluble fusion protein that consists of the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) linked to the m...
View ProductTablets
XADAGO tablets contain safinamide, which is a MAO-B inhibitor, as the mesylate salt. XADAGO Safinamide mesylate is a white to off-white crystalline powder. Safinamide mesylate is freely soluble in wat...
XADAGO tablets contain safinamide, which is a MAO-B inhibitor, as the mesylate salt. XADAGO Safinamide mesylate is a white to off-white crystalline powder. Safinamide mesylate is freely soluble in wat...
View ProductTablets
MAYZENT® (siponimod) tablets, for oral use
Injection
EMGALITY (galcanezumab-gnlm) injection, for subcutaneous use. EMGALITY® is a calcitonin-gene related peptide Antagonist indicated in adults for the • preventive treatment of migraine. • treatment of e...
EMGALITY (galcanezumab-gnlm) injection, for subcutaneous use. EMGALITY® is a calcitonin-gene related peptide Antagonist indicated in adults for the • preventive treatment of migraine. • treatment of e...
View ProductPowder
RELYVRIO (sodium phenylbutyrate and taurursodiol), for oral suspension.
RELYVRIO (sodium phenylbutyrate and taurursodiol), for oral suspension.
View ProductTablets
"MAVENCLAD is indicated for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency of clinical relapses and to delay the progression of physical disability. Followin...
"MAVENCLAD is indicated for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency of clinical relapses and to delay the progression of physical disability. Followin...
View ProductTablets
MAYZENT® (siponimod) is a sphingosine 1-phosphate (S1P) receptor modulator and is for oral use.
MAYZENT® (siponimod) is a sphingosine 1-phosphate (S1P) receptor modulator and is for oral use.
View ProductInjection
COPAXONE (glatiramer acetate injection), for subcutaneous use
COPAXONE (glatiramer acetate injection), for subcutaneous use
View ProductInjection
OCREVUS is a CD20-directed cytolytic antibody indicated for the treatment of Multiple Sclerosis.
OCREVUS is a CD20-directed cytolytic antibody indicated for the treatment of Multiple Sclerosis.
View ProductInjection
COLUMVI (glofitamab-gxbm) is a bispecific CD20-directed CD3 T-cell engager. COLUMVI (glofitamab-gxbm) injection is a sterile, preservative-free, colorless, clear solution supplied in single-dose vials...
COLUMVI (glofitamab-gxbm) is a bispecific CD20-directed CD3 T-cell engager. COLUMVI (glofitamab-gxbm) injection is a sterile, preservative-free, colorless, clear solution supplied in single-dose vials...
View ProductTablets
VANFLYTA (quizartinib) is a kinase inhibitor for oral use. VANFLYTA is supplied as film-coated tablets containing 17.7 mg or 26.5 mg of quizartinib, which are equivalent to 20 mg and 30 mg quizartinib...
VANFLYTA (quizartinib) is a kinase inhibitor for oral use. VANFLYTA is supplied as film-coated tablets containing 17.7 mg or 26.5 mg of quizartinib, which are equivalent to 20 mg and 30 mg quizartinib...
View ProductInjection
ELREXFIO (elranatamab-bcmm) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. It is a bispecific,humanized immunoglobulin 2-alanine (IgG2Δa) kappa antibody derived from two...
ELREXFIO (elranatamab-bcmm) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. It is a bispecific,humanized immunoglobulin 2-alanine (IgG2Δa) kappa antibody derived from two...
View ProductInjection
TALQUETAMAB 40 MG INJECTION<br> TALVEY (talquetamab-tgvs) is a bispecific GPRC5D-directed CD3 T-cell engager. It is a humanized IgG4 proline, alanine, alanine (IgG4-PAA)-based bispecific antibody pro...
TALQUETAMAB 40 MG INJECTION<br> TALVEY (talquetamab-tgvs) is a bispecific GPRC5D-directed CD3 T-cell engager. It is a humanized IgG4 proline, alanine, alanine (IgG4-PAA)-based bispecific antibody pro...
View ProductCapsules
NINLARO (ixazomib) is an antineoplastic agent. NINLARO (ixazomib) capsules for oral use contain 4, 3 or 2.3 mg of ixazomib equivalent to 5.7, 4.3 or 3.3 mg of ixazomib citrate, respectively. Inactive...
NINLARO (ixazomib) is an antineoplastic agent. NINLARO (ixazomib) capsules for oral use contain 4, 3 or 2.3 mg of ixazomib equivalent to 5.7, 4.3 or 3.3 mg of ixazomib citrate, respectively. Inactive...
View ProductInjection
ELOTUZUMAB 300 / 400 MG INJECTION <br> EMPLICITI (elotuzumab) is a humanized recombinant monoclonal antibody directed to SLAMF7, a cell surface glycoprotein. Elotuzumab consists of the complementary...
ELOTUZUMAB 300 / 400 MG INJECTION <br> EMPLICITI (elotuzumab) is a humanized recombinant monoclonal antibody directed to SLAMF7, a cell surface glycoprotein. Elotuzumab consists of the complementary...
View ProductInjection
NULOJIX (belatacept), a selective T cell costimulation blocker, is a soluble fusion protein consisting of the modified extracellular domain of CTLA-4 fused to a portion (hinge-CH2-CH3 domains) of the...
NULOJIX (belatacept), a selective T cell costimulation blocker, is a soluble fusion protein consisting of the modified extracellular domain of CTLA-4 fused to a portion (hinge-CH2-CH3 domains) of the...
View ProductInjection
Daunorubicin is an anthracycline topoisomerase inhibitor, & Cytarabine is a nucleoside metabolic inhibitor. VYXEOS (daunorubicin and cytarabine) liposome for injection is a combination of daunorubicin...
Daunorubicin is an anthracycline topoisomerase inhibitor, & Cytarabine is a nucleoside metabolic inhibitor. VYXEOS (daunorubicin and cytarabine) liposome for injection is a combination of daunorubicin...
View ProductTablets
TIBSOVO (ivosidenib) is an inhibitor of isocitrate dehydrogenase 1 (IDH1) enzyme. TIBSOVO (ivosidenib) is available as a film-coated 250 mg tablet for oral administration. Each tablet contains the fol...
TIBSOVO (ivosidenib) is an inhibitor of isocitrate dehydrogenase 1 (IDH1) enzyme. TIBSOVO (ivosidenib) is available as a film-coated 250 mg tablet for oral administration. Each tablet contains the fol...
View ProductTablets
LETERMOVIR 240 MG TABLETS <br> PREVYMIS (letermovir) contains letermovir, an inhibitor of the CMV DNA terminase complex, and is administered orally or by intravenous infusio. PREVYMIS is available as...
LETERMOVIR 240 MG TABLETS <br> PREVYMIS (letermovir) contains letermovir, an inhibitor of the CMV DNA terminase complex, and is administered orally or by intravenous infusio. PREVYMIS is available as...
View ProductTablets
ENASIDENIB 50 / 100 MG TABLETS<br> IDHIFA (enasidenib) is an inhibitor of isocitrate dehydrogenase-2 (IDH2) enzyme. IDHIFA (enasidenib) is available as a 50-mg tablet (equivalent to 60 mg enasidenib...
ENASIDENIB 50 / 100 MG TABLETS<br> IDHIFA (enasidenib) is an inhibitor of isocitrate dehydrogenase-2 (IDH2) enzyme. IDHIFA (enasidenib) is available as a 50-mg tablet (equivalent to 60 mg enasidenib...
View ProductInjection
BELANTAMAB MAFODOTIN 100 MG INJECTION <br> BLENREP (belantamab mafodotin-blmf) is a B-cell maturation antigen (BCMA)-directed antibody and microtubule inhibitor conjugate, BLENREP (belantamab mafodot...
BELANTAMAB MAFODOTIN 100 MG INJECTION <br> BLENREP (belantamab mafodotin-blmf) is a B-cell maturation antigen (BCMA)-directed antibody and microtubule inhibitor conjugate, BLENREP (belantamab mafodot...
View ProductInjection
NELARABINE 250 MG INJECTION<br> ARRANON (nelarabine) Injection is supplied as a clear, colorless, sterile solution in glass vials. Each 258 vial contains 250 mg of nelarabine (5 mg nelarabine per mL)...
NELARABINE 250 MG INJECTION<br> ARRANON (nelarabine) Injection is supplied as a clear, colorless, sterile solution in glass vials. Each 258 vial contains 250 mg of nelarabine (5 mg nelarabine per mL)...
View ProductInjection
BLINATUMOMAB 35 MCG INJECTION <br> BLINCYTO (blinatumomab) is a bispecific CD19-directed1 CD3 T-cell engager that binds to CD19 (expressed on cells of B-lineage origin) and CD3 (expressed on T cells)...
BLINATUMOMAB 35 MCG INJECTION <br> BLINCYTO (blinatumomab) is a bispecific CD19-directed1 CD3 T-cell engager that binds to CD19 (expressed on cells of B-lineage origin) and CD3 (expressed on T cells)...
View ProductTablets
PONATINIB 15 / 30 MG TABLETS <br> ICLUSIG (ponatinib) is a kinase inhibitor. Iclusig tablets are available as white, round, film-coated tablets for oral administration. Each tablet contains ponatinib...
PONATINIB 15 / 30 MG TABLETS <br> ICLUSIG (ponatinib) is a kinase inhibitor. Iclusig tablets are available as white, round, film-coated tablets for oral administration. Each tablet contains ponatinib...
View ProductTablets
Venetoclax 100 mg TABLET <br> VENCLEXTA (venetoclax) tablets for oral administration are supplied as pale yellow or beige tablets that contain 10, 50, or 100 mg venetoclax as the active ingredient. E...
Venetoclax 100 mg TABLET <br> VENCLEXTA (venetoclax) tablets for oral administration are supplied as pale yellow or beige tablets that contain 10, 50, or 100 mg venetoclax as the active ingredient. E...
View ProductInjection
DOSTARLIMAB 500 MG/10 ML INJECTION<br> JEMPERLI (dostarlimab-gxly) is a programmed death receptor-1 (PD-1)–blocking IgG4 humanized monoclonal antibody. JEMPERLI (dostarlimab-gxly) injection is a ster...
DOSTARLIMAB 500 MG/10 ML INJECTION<br> JEMPERLI (dostarlimab-gxly) is a programmed death receptor-1 (PD-1)–blocking IgG4 humanized monoclonal antibody. JEMPERLI (dostarlimab-gxly) injection is a ster...
View ProductInjection
UNITTXIN (dinutuximab) is a chimeric monoclonal antibody composed of murine variable heavy and light chain regions and the human constant region for the heavy chain IgG1 and light chain kappa. Unituxi...
UNITTXIN (dinutuximab) is a chimeric monoclonal antibody composed of murine variable heavy and light chain regions and the human constant region for the heavy chain IgG1 and light chain kappa. Unituxi...
View ProductCapsules
"KOSELUGO (selumetinib) is a kinase inhibitor.KOSELUGO (selumetinib) 10 mg capsules for oral use, contain 10 mg selumetinib (equivalent to12.1 mg selumetinib sulfate) and the excipient, vitamin E poly...
"KOSELUGO (selumetinib) is a kinase inhibitor.KOSELUGO (selumetinib) 10 mg capsules for oral use, contain 10 mg selumetinib (equivalent to12.1 mg selumetinib sulfate) and the excipient, vitamin E poly...
View ProductCapsules
SELPERCATINIB 40 & 80 MG TABLETS<br> "RETEVMO (selpercatinib) is a kinase inhibitor. RETEVMO (selpercatinib) is supplied as 40 mg or 80 mg hard gelatin capsules for oral use. Each capsule contains in...
SELPERCATINIB 40 & 80 MG TABLETS<br> "RETEVMO (selpercatinib) is a kinase inhibitor. RETEVMO (selpercatinib) is supplied as 40 mg or 80 mg hard gelatin capsules for oral use. Each capsule contains in...
View ProductTablets
TRIFLURIDINE & TIPIRACIL 15 MG AND 20 MG TABLETS<br> "LONSURF contains trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5. Each film-coated tablet of LONSURF, for oral use, contains 2...
TRIFLURIDINE & TIPIRACIL 15 MG AND 20 MG TABLETS<br> "LONSURF contains trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5. Each film-coated tablet of LONSURF, for oral use, contains 2...
View ProductTablets
"PIQRAY (alpelisib) is a kinase inhibitor. PIQRAY film-coated tablets are supplied for oral administration with three strengths that contain 50 mg, 150 mg and 200 mg of alpelisib. The tablets also con...
"PIQRAY (alpelisib) is a kinase inhibitor. PIQRAY film-coated tablets are supplied for oral administration with three strengths that contain 50 mg, 150 mg and 200 mg of alpelisib. The tablets also con...
View ProductCapsules
HYCAMTIN (topotecan hydrochloride) is a semi-synthetic derivative of camptothecin and is an anti-tumor drug with topoisomerase I-inhibitory activity. HYCAMTIN capsules contain topotecan hydrochloride,...
HYCAMTIN (topotecan hydrochloride) is a semi-synthetic derivative of camptothecin and is an anti-tumor drug with topoisomerase I-inhibitory activity. HYCAMTIN capsules contain topotecan hydrochloride,...
View ProductTablets
ALUNBRIG (brigatinib) is a kinase inhibitor. ALUNBRIG is supplied for oral use as film-coated tablets containing 180 mg, 90 mg or 30 mg of brigatinib and the following inactive ingredients: lactose mo...
ALUNBRIG (brigatinib) is a kinase inhibitor. ALUNBRIG is supplied for oral use as film-coated tablets containing 180 mg, 90 mg or 30 mg of brigatinib and the following inactive ingredients: lactose mo...
View ProductTablets
MITOTANE 500 MG TABLETS<br> LYSODREN (mitotane tablets, USP) is an oral chemotherapeutic agent. LYSODREN is a white granular solid composed of clear colorless crystals. It is tasteless and has a slig...
MITOTANE 500 MG TABLETS<br> LYSODREN (mitotane tablets, USP) is an oral chemotherapeutic agent. LYSODREN is a white granular solid composed of clear colorless crystals. It is tasteless and has a slig...
View ProductInjection
LIPOSOMAL IRINOTECAN INJECTION<br> ONIVYDE (liposomal irinotecan) is formulated with irinotecan hydrochloride trihydrate, a topoisomerase inhibitor, into a liposomal dispersion for intravenous use. O...
LIPOSOMAL IRINOTECAN INJECTION<br> ONIVYDE (liposomal irinotecan) is formulated with irinotecan hydrochloride trihydrate, a topoisomerase inhibitor, into a liposomal dispersion for intravenous use. O...
View ProductCapsules
ZEJULA (niraparib) is an orally available poly(ADP-ribose) polymerase (PARP) inhibitor. Each ZEJULA capsule contains 159.4 mg niraparib tosylate monohydrate equivalent to 100 mg niraparib free base as...
ZEJULA (niraparib) is an orally available poly(ADP-ribose) polymerase (PARP) inhibitor. Each ZEJULA capsule contains 159.4 mg niraparib tosylate monohydrate equivalent to 100 mg niraparib free base as...
View ProductCapsules
LAROTRECTINIB 25 AND 100 MG CAPSULES<br> VITRAKVI (larotrectinib) is a kinase inhibitor. VITRAKVI (larotrectinib) capsules and oral solution are formulated using larotrectinib sulfate. VITRAKVI (lar...
LAROTRECTINIB 25 AND 100 MG CAPSULES<br> VITRAKVI (larotrectinib) is a kinase inhibitor. VITRAKVI (larotrectinib) capsules and oral solution are formulated using larotrectinib sulfate. VITRAKVI (lar...
View ProductTablets
NERLYNX (neratinib) immediate release, film-coated tablets for oral administration contain 40 mg of neratinib, equivalent to 48.31 mg neratinib maleate. Neratinib is a member of the 4-anilino quinolid...
NERLYNX (neratinib) immediate release, film-coated tablets for oral administration contain 40 mg of neratinib, equivalent to 48.31 mg neratinib maleate. Neratinib is a member of the 4-anilino quinolid...
View ProductCapsules
TALZENNA (talazoparib) is an inhibitor of mammalian polyadenosine 5’-diphosphoribose polymerase (PARP) enzyme. Inactive ingredients: silicified microcrystalline cellulose (sMCC). The capsule shells co...
TALZENNA (talazoparib) is an inhibitor of mammalian polyadenosine 5’-diphosphoribose polymerase (PARP) enzyme. Inactive ingredients: silicified microcrystalline cellulose (sMCC). The capsule shells co...
View ProductTablets
TUCATINIB 50 AND 150 MG TABLETS<br> TUKYSA (tucatinib) is a kinase inhibitor. TUKYSA (tucatinib) is supplied as 50 mg and 150 mg film-coated tablets for oral use and contain the following inactive i...
TUCATINIB 50 AND 150 MG TABLETS<br> TUKYSA (tucatinib) is a kinase inhibitor. TUKYSA (tucatinib) is supplied as 50 mg and 150 mg film-coated tablets for oral use and contain the following inactive i...
View ProductTablets
"KRAZATI (adagrasib) is an irreversible inhibitor of KRAS G12C and belongs to the RAS GTPase family. KRAZATI (adagrasib) tablets for oral administration contain 200 mg of adagrasib. The following are...
"KRAZATI (adagrasib) is an irreversible inhibitor of KRAS G12C and belongs to the RAS GTPase family. KRAZATI (adagrasib) tablets for oral administration contain 200 mg of adagrasib. The following are...
View ProductInjection
SACITUZUMAB GOVITECAN 180 MG INJECTION<br> TRODELVY (sacituzumab govitecan-hziy) is a Trop-2 directed antibody and topoisomerase inhibitor conjugate, composed of the following three components: • the...
SACITUZUMAB GOVITECAN 180 MG INJECTION<br> TRODELVY (sacituzumab govitecan-hziy) is a Trop-2 directed antibody and topoisomerase inhibitor conjugate, composed of the following three components: • the...
View ProductCapsules
ENCORAFENIB 50 MG AND 75 MG CAPSULES<br> BRAFTOVI (encorafenib) is a kinase inhibitor. BRAFTOVI (encorafenib) capsules for oral use contain 50 mg or 75 mg of encorafenib with the following inactive i...
ENCORAFENIB 50 MG AND 75 MG CAPSULES<br> BRAFTOVI (encorafenib) is a kinase inhibitor. BRAFTOVI (encorafenib) capsules for oral use contain 50 mg or 75 mg of encorafenib with the following inactive i...
View ProductTablets
VEMURAFENIB 240 MG TABLETS <br> ZELBORAF (vemurafenib) is a kinase inhibitor available as 240 mg tablets for oral use. Tablets of ZELBORAF are for oral administration. Each tablet contains 240 mg of...
VEMURAFENIB 240 MG TABLETS <br> ZELBORAF (vemurafenib) is a kinase inhibitor available as 240 mg tablets for oral use. Tablets of ZELBORAF are for oral administration. Each tablet contains 240 mg of...
View ProductTablets
BINIMETINIB 15 MG TABLETS <br> MEKTOVI (binimetinib) is a kinase inhibitor. MEKTOVI (binimetinib) tablets for oral use contain 15 mg of binimetinib with the following inactive ingredients: lactose mo...
BINIMETINIB 15 MG TABLETS <br> MEKTOVI (binimetinib) is a kinase inhibitor. MEKTOVI (binimetinib) tablets for oral use contain 15 mg of binimetinib with the following inactive ingredients: lactose mo...
View ProductCapsules
ENTRECTINIB 100 / 200 MG CAPSULES<br> ROZLYTREK (entrectinib) is a kinase inhibitor. ROZLYTREK (entrectinib) capsules for oral use are supplied as printed hard-shell capsules containing 100 mg (yello...
ENTRECTINIB 100 / 200 MG CAPSULES<br> ROZLYTREK (entrectinib) is a kinase inhibitor. ROZLYTREK (entrectinib) capsules for oral use are supplied as printed hard-shell capsules containing 100 mg (yello...
View ProductInjection
ENFORTUMAB VEDOTIN EJFV 20/30 MG INJECTION<br> "PADCEV (enfortumab vedotin-ejfv) is a Nectin-4 directed antibody-drug conjugate (ADC) comprised of a fully human anti-Nectin-4 IgG1 kappa monoclonal a...
ENFORTUMAB VEDOTIN EJFV 20/30 MG INJECTION<br> "PADCEV (enfortumab vedotin-ejfv) is a Nectin-4 directed antibody-drug conjugate (ADC) comprised of a fully human anti-Nectin-4 IgG1 kappa monoclonal a...
View Product
Dear Mr. Rahman,
The emotional and psychological effects of a disease like cancer is beyond description, not only for the patient, but also for their near and dear ones. Being diagnosed with cancer one fine morning is a panicky situation that can be overcome only with the support of a treating physician and associated people. The least in the mind of the family will be the availability of medication to start the treatment as early as possible.
Read More...
Dear Mr Rahman,
Good Day.
It's a pleasure to write a testimonial for you:
I just wanted to write and thank Mr Rahman, Impomed Healthcare for the exceptional service provided to my sister's cancer drug medications (in a very short order), which was imported from Turkey during the tough Covid -pandemic times, including the regulatory aspects, procurement (limited and restricted international flights) and local
Read More...
It's a pleasure to write a testimonial for you:
I just wanted to write and thank Mr Rahman, Impomed Healthcare for the exceptional service provided to my sister's cancer drug medications (in a very short order), which was imported from Turkey during the tough Covid -pandemic times, including the regulatory aspects, procurement (limited and restricted international flights) and local
Read More...
Hi Rahman,
I am writing to express my sincere gratitude for the outstanding service you have provided to me as my pharmaceutical dealer. Your attention to detail, prompt response, and excellent customer service have made my experience with your company a truly positive one.
I especially want to thank you for your assistance in providing me with my regular medication. Your efforts have ensured that I always have the medication
Read More...
Dear Mr Rahman,
I am really impressed by the dedication you showed to arrange my medicine (Ponatinib) in a short period of time. The help you extended afterward is worth mentioning. Keep up the good work in the future as well. All the best. Once again heartfelt thanks to you.
I would like to thank Mr. Rahman. I had an amazing experience with your company Impomed Healthcare. I was so pleased with the service I received from you. It was a difficult time for me when the doctor prescribed a medicine (Tab. VENETOCLAX) for my wife, which was not available in India. You procured and delivered this medicine through the legal process in a very short time.
Keep doing good work in the future. Best wishes Once again thank you very much.
Dear Mr Rahman,
I imported medicine (Tab. Venetoclax 100 mg) for my father’s treatment from ImpoMed Healthcare Pvt. Ltd. Mr. Rahman is the owner of the company and the person who dealt with me throughout the whole process. His generous nature and time-bound delivery attitude were very impressive. We made every step of the process very easy and communicative. He even ensured that medicine reached safely to me.
Mr. Rehman
Thank you so much for coordinating the import of my life-saving drug - Trodelvy (Sacituzumab Govitcan) for me in a very professional and timely manner. Your guidance and prompt service was much appreciated and I will definitely recommend everyone I know to go through your service to import medicines. You knew the process very well and had everything planned very meticulously to ensure that the patient doesn’t have to suffer in this process.